4.8 Article

GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
News Item Dermatology

Structural Studies of Mas-Related G Protein-Coupled Receptors

E. Lerner

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Cell Biology

NF-κB perturbation reveals unique immunomodulatory functions in Prx1+ fibroblasts that promote development of atopic dermatitis

Kang Ko et al.

Summary: The study reveals the important role of a specific subpopulation of Prx1(+) fibroblasts in immune regulation of the skin. Disruption of the Ikkb-NF-kappa B pathway in these fibroblasts triggers skin inflammation and results in overexpression of CCL11, leading to eosinophil infiltration and T(H)2 immune response, resembling human atopic dermatitis. Monoclonal antibody treatment targeting CCL11 shows promising efficacy in a mouse model.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Immunology

The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity

Polina Pyatilova et al.

Summary: High numbers of MRGPRX2+ cells were found in skin lesions of patients with mastocytosis, although they were not linked to symptom severity.

FRONTIERS IN IMMUNOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Paroxetine Attenuates Cardiac Hypertrophy Via Blocking GRK2 and ADRB1 Interaction in Hypertension

Xuejing Sun et al.

Summary: This study revealed the association of GRK2 and ADRB1 expressions in hypertensive patients with blood pressure levels and cardiac pathology. Paroxetine treatment attenuated cardiac hypertrophy by promoting ADRB1 sensitivity and blocking GRK2-mediated ADRB1 activation and internalization in hypertension.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Multidisciplinary Sciences

Structure, function and pharmacology of human itch receptor complexes

Fan Yang et al.

Summary: MRGPRX2 is a key receptor involved in sensing basic secretagogues and eliciting itch signals and pseudoallergic reactions. The structures of its complex with G(i1) revealed shallow ligand-binding pockets and unique activation processes, providing a structural basis for designing therapies to prevent unwanted pseudoallergic reactions.

NATURE (2021)

Review Biochemistry & Molecular Biology

Paroxetine-Overview of the Molecular Mechanisms of Action

Magdalena Kowalska et al.

Summary: Diagnosis and treatment of depression are crucial in modern medicine, especially among adolescents. Anxiety disorders are common in children and adolescents, with social phobias being a significant type. Treatment typically involves psychotherapy and pharmacotherapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Allergy

A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice

Katharina Wolf et al.

Summary: Mas gene-related G protein-coupled receptors (MRGPRs) play a fundamental role in pain and itch sensation, with MRGPRX2 and its murine orthologue MRGPRB2 mediating pseudoallergic drug reactions. The study identified a class of commonly used drugs that activate MRGPRX2, primarily consisting of cationic amphiphilic drugs, leading to degranulation of mast cells and scratching behavior in both human and mice models. This research contributes to understanding the structure-activity relationships and functionality of MRGPRX2 ligands to predict and prevent adverse reactions such as drug-induced pruritus.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Cell Biology

Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis

Elijah L. Carlson et al.

Summary: Osteoarthritis (OA) is a degenerative joint disease with no effective disease-modifying therapy. Inhibition of GRK2 has been shown to prevent cartilage degeneration and promote regeneration in OA, with the antidepressant paroxetine identified as a potential disease-modifying drug for OA treatment.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Allergy

Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease

Saptarshi Roy et al.

Summary: MRGPRX2, activated by various cationic ligands, plays a role in host defense but overactivation may lead to pseudoallergy and various skin diseases. Gain and loss-of-function missense polymorphisms have been identified in MRGPRX2, and the functionality of certain ligands has been defined. The development of small-molecule HDP mimetics that activate MRGPRX2 presents a new therapeutic approach, while MRGPRX2-specific antibodies and inhibitors could be utilized for modulation of allergic and inflammatory diseases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Immunology

Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells via MRGPRX2 and MrgprB2

Aetas Amponnawarat et al.

Summary: Pseudomonas aeruginosa infections are difficult to treat due to biofilm formation and antibiotic resistance, but a lipidated HDP mimetic called murepavadin has shown antibacterial activity against multi-drug-resistant strains. Murepavadin activates human MCs via MRGPRX2 and murine MCs via MrgprB2, potentially contributing to bacterial clearance and wound healing.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

MRGPRX2 and Adverse Drug Reactions

Benjamin D. McNeil

Summary: Adverse reactions to therapeutic drugs are thought to be triggered by patient-specific IgE antibodies recognizing drug molecules, but another proposed mechanism involves direct mast cell degranulation activation via MRGPRX2 receptor. Mild-to-moderate events triggered by MRGPRX2 activation may be more common than currently appreciated, even after administration of high doses for some drugs.

FRONTIERS IN IMMUNOLOGY (2021)

Letter Allergy

Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis

Vishwa Deepak et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Multidisciplinary Sciences

Structure, function and pharmacology of human itch GPCRs

Can Cao et al.

Summary: Structural studies of MRGPRX2 and MRGPRX4 in complex with endogenous and synthetic ligands provide insights for developing therapeutic compounds for pain, itch, and mast cell-mediated hypersensitivity. These receptors are key mediators of itch and related mast cell-mediated hypersensitivity reactions.

NATURE (2021)

Article Allergy

G Protein-Coupled Receptor Kinase 2 (GRK2) Regulates T Cell Response in a Murine Model of House Dust Mite-Induced Asthma

Ananth K. Kammala et al.

Summary: GRK2 is an adapter protein that modulates GPCR signaling and regulates the functions of intracellular proteins in various cell types. Elevated levels of GRK2 are observed in the lungs of asthma patients and in mouse asthma models, leading to decreased levels of interleukins. By regulating T cell responses, GRK2 plays a crucial role in asthma pathogenesis.

FRONTIERS IN ALLERGY (2021)

Article Pharmacology & Pharmacy

A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor

Renee A. Bouley et al.

MOLECULAR PHARMACOLOGY (2020)

Article Allergy

β-Arrestin2 expressed in mast cells regulates ciprofloxacin-induced pseudoallergy and IgE-mediated anaphylaxis

Saptarshi Roy et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub

Petronila Penela et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Article Multidisciplinary Sciences

MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia

Arnau Navines-Ferrer et al.

SCIENTIFIC REPORTS (2018)

Article Biotechnology & Applied Microbiology

Trends in GPCR drug discovery: new agents, targets and indications

Alexander S. Hauser et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Biochemistry & Molecular Biology

Modulation of host defense peptide-mediated human mast cell activation by LPS

Kshitij Gupta et al.

INNATE IMMUNITY (2016)

Article Cell Biology

Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction

Sarah M. Schumacher et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Multidisciplinary Sciences

Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions

Benjamin D. McNeil et al.

NATURE (2015)

Article Biochemistry & Molecular Biology

Regulation of FcεRI Signaling in Mast Cells by G Protein-coupled Receptor Kinase 2 and Its RH Domain

Hariharan Subramanian et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Allergy

Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation

Merritt L. Fajt et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

Paroxetine Is a Direct Inhibitor of G Protein-Coupled Receptor Kinase 2 and Increases Myocardial Contractility

David M. Thal et al.

ACS CHEMICAL BIOLOGY (2012)

Review Biochemistry & Molecular Biology

IgE and mast cells in allergic disease

Stephen J. Galli et al.

NATURE MEDICINE (2012)

Review Immunology

Mast cells in atopic dermatitis

Toshiaki Kawakami et al.

CURRENT OPINION IN IMMUNOLOGY (2009)

Article Biochemistry & Molecular Biology

The membrane-proximal portion of CD3 ∈ associates with the serine/threonine kinase GRK2

Laura M. DeFord-Watts et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Cardiac & Cardiovascular Systems

Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease

P Penela et al.

CARDIOVASCULAR RESEARCH (2006)

Article Immunology

Activation of murine lung mast cells by the adenosine A3 receptor

H Zhong et al.

JOURNAL OF IMMUNOLOGY (2003)

Article Health Care Sciences & Services

Paroxetine in the treatment of severe non-dermatological pruritus: A randomized, controlled trial

Z Zylicz et al.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2003)

Article Infectious Diseases

Antimicrobial activity of psychotropic drugs -: Selective serotonin reuptake inhibitors

JL Munoz-Bellido et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)